“…Therefore, it is important to identify other prognostic factors to improve the ability of the TNM staging system to predict prognosis. In recent years, there have been several published reports focusing on the correlation between the prognosis of NPC patients treated with IMRT and tumour-or host-related factors, such as the primary tumour volume (GTV-P) (Guo et al 2012;Chen et al 2011), the maximum standardized uptake value of the primary tumour (SUVmax-P), which is tested by 18 F-FDG PET/CT , weight loss during treatment (Qiu et al 2011), baseline serum LDH levels Zhou et al 2012), and the albumin-globulin ratio before treatment (pretreatment AGR) . The results of those studies indicated that advanced large GTV-P (Guo et al 2012;Chen et al 2011), high SUVmax-P , high weight loss during treatment (Qiu et al 2011), high baseline serum LDH levels Zhou et al 2012) and lower pretreatment AGR all are predictors of a poor prognosis and could be used to facilitate treatment options when combined with the TNM staging system.…”